Teva announces senior leadership changes

Israel-based Teva Pharmaceutical Industries has announced a new organizational structure and related executive positions. Effective July 1, 2014, Teva will be spearheaded by two commercial business units – Global Specialty Medicines (GSM), established in April 2013, and the newly-formed Global Generic Medicines group (GGM).

“The new organizational structure and leadership team will better position Teva to deliver sustainable growth and create short and long-term value. We must capitalize first on our existing assets and capabilities, and exploit opportunities and synergies emanating from the full integration of all business activities – most importantly, generic and specialty – while leveraging our global R&D and operations capabilities," said Teva's president and chief executive Erez Vigodman.

Global Generic Medicines (GGM)